COMPARISON OF THE INCIDENCE OF LATENT PROSTATE CANCER DETECTED AT AUTOPSY BEFORE AND AFTER THE PROSTATE SPECIFIC ANTIGEN ERA
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 174 (5) , 1785-1788
- https://doi.org/10.1097/01.ju.0000177470.84735.55
Abstract
Most data regarding the prevalence of latent prostate cancer found only at autopsy are from old reports. To determine if significant differences exist in the prevalence of latent prostate cancer between periods before and after the advent of screening for prostate cancer, we compared 2 groups of men undergoing autopsy during the 2 periods. Our institutional autopsy record database was searched to identify all men found to have prostate cancer before or after death between 1955 and 1960 (total 3,307 men and 1,578 men older than 40 years), and between 1991 and 2001 (total 2,938 men, 1,380 men older than 40 years). We calculated the age based incidence of latent prostate cancer detected only at autopsy in an at risk population of men (older than 40 years). We also compared Gleason grade distribution and proportion of stage cT3 or greater cancers between the 2 periods. Between 1955 and 1960 the prevalence of latent prostate cancer detected only at autopsy in men older than 40 years was 4.8% compared to 1.2% (p < 0.0001) between 1991 and 2001. A significant decrease in the prevalence of latent, autopsy detected cancers was observed in men 70 to 89 years old at death. Autopsy detected cancers were found to be grossly invading adjacent structures (stage cT3 or greater) in 17 of 76 (22%) cancers discovered between 1955 and 1960, while none of the latent prostate cancers found in the 1991 to 2001 period were found to extend grossly beyond the prostate. Autopsy rates are decreasing at our institution. With the more widespread use of screening, the prevalence of latent prostate cancer has decreased 3-fold. The decrease in the prevalence of latent prostate cancer is especially dramatic in men older than 70 years. Further study will determine the significance of many of the tumors currently detected clinically, which may have been latent and found at autopsy if not for screening.Keywords
This publication has 13 references indexed in Scilit:
- Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patientsUrology, 2003
- Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostateUrologic Oncology: Seminars and Original Investigations, 2002
- Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence TrendsJNCI Journal of the National Cancer Institute, 2002
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Prostate cancer incidence and mortality in the United States and the United Kingdom.JNCI Journal of the National Cancer Institute, 1998
- Trends in Frequency of Latent Prostate Carcinoma in Japan from 1965-1979 to 1982-1986JNCI Journal of the National Cancer Institute, 1988
- Geographic pathology of latent prostatic carcinomaInternational Journal of Cancer, 1982
- Latent Prostatic Cancer in a Consecutive Autopsy SeriesScandinavian Journal of Urology and Nephrology, 1980
- Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, FranceInternational Journal of Cancer, 1977
- Latent carcinoma of the prostateThe Journal of Pathology and Bacteriology, 1954